HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Yusuke Iwata Toru Okamura Nobuyuki Ishibashi Richard A. Jonas Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Iwata, Y. Articles by Jonas, R. A. Search for Related Content PubMed Articles by Iwata, Y. Articles by Jonas, R. A. Related Collections Extracorporeal circulation

J Thorac Cardiovasc Surg 2009;137:1521-1529
© 2009 The American Association for Thoracic Surgery

Cardiopulmonary Support

Optimal dose of aprotinin for neuroprotection and renal function in a piglet survival model

Division of Cardiac Surgery, Children's National Medical Center, Washington, DC

Received for publication May 4, 2008; accepted for publication June 10, 2008.

^_* Address for reprints: Richard A. Jonas, MD, Children's National Heart Institute, Children's National Medical Center, 111 Michigan Ave NW, Washington, DC 20010. (Email: rjonas{at}cnmc.org).

Objective: The efficacy of aprotinin in reducing blood loss after cardiopulmonary bypass is well established, although its neuroprotective potential is less well known. Furthermore, there is controversy regarding optimal dosing and possible renal complications.

Methods: Fifty-four piglets were randomized to one of 3 cardiopulmonary bypass groups designed to carry the risk of postoperative cerebral and renal dysfunction: circulatory arrest at 25°C and ultra–low flow bypass (10 mL · kg^–1 · min^–1) at either 25°C or 34°C. Animals were randomized to the following groups: control (no aprotinin), low dose (30,000 KIU/kg into prime only), standard full dose (30,000 KIU/kg bolus administered intravenously into prime plus 10,000 KIU/kg infusion), and double full dose. The tissue oxygenation index was monitored by means of near-infrared spectroscopy. Neurologic functional and histologic scores and creatinine and blood urea nitrogen values were outcomes of interest.

Results: Aprotinin significantly improved neurologic scores on postoperative day 1 after ultra–low-flow bypass at 25°C or 34°C (P < .01) but not after hypothermic circulatory arrest (P = .57). Linear regression indicated a strong dose-response relationship, with higher aprotinin doses having the best neurologic scores. During low-flow bypass, a higher tissue oxygenation index was correlated with a higher aprotinin dose (P < .05). Aprotinin dose had no significant effect on creatinine or blood urea nitrogen values on day 1. Low body weight was the only predictor of high blood urea nitrogen values (r = –0.39, P < .01).

Conclusion: Aprotinin significantly improves neurologic recovery without compromising renal function in the young piglet.

This article has been cited by other articles:

				T. Okamura, N. Ishibashi, D. Zurakowski, and R. A. Jonas Cardiopulmonary Bypass Increases Permeability of the Blood-Cerebrospinal Fluid Barrier. Ann. Thorac. Surg., January 1, 2010; 89(1): 187 - 194. [Abstract] [Full Text] [PDF]

				N Ishibashi, Y Iwata, D Zurakowski, H. Lidov, and R. Jonas Aprotinin protects the cerebral microcirculation during cardiopulmonary bypass Perfusion, March 1, 2009; 24(2): 99 - 105. [Abstract] [PDF]